MENU
+Compare
BLFS
Stock ticker: NASDAQ
AS OF
Oct 6, 04:59 PM (EDT)
Price
$26.52
Change
-$0.07 (-0.26%)
Capitalization
1.27B

BLFS BioLife Solutions Forecast, Technical & Fundamental Analysis

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry... Show more

BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for BLFS with price predictions
Oct 03, 2025

BLFS in upward trend: price may ascend as a result of having broken its lower Bollinger Band on September 23, 2025

BLFS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where BLFS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 03, 2025. You may want to consider a long position or call options on BLFS as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BLFS just turned positive on October 03, 2025. Looking at past instances where BLFS's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for BLFS moved above the 200-day moving average on October 01, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BLFS advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 201 cases where BLFS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for BLFS moved out of overbought territory on September 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLFS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BLFS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLFS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.670) is normal, around the industry mean (10.969). P/E Ratio (0.000) is within average values for comparable stocks, (54.450). BLFS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.741). BLFS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (13.351) is also within normal values, averaging (14.774).

View a ticker or compare two or three
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

BLFS is expected to report earnings to fall 96.21% to -1 cents per share on November 06

BioLife Solutions BLFS Stock Earnings Reports
Q3'25
Est.
$-0.01
Q2'25
Missed
by $0.30
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.04
The last earnings report on August 07 showed earnings per share of -33 cents, missing the estimate of -2 cents. With 303.14K shares outstanding, the current market capitalization sits at 1.27B.
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary and generic bio preservation media products for cells, tissues and organs

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3303 Monte Villa Parkway
Phone
+1 425 402-1400
Employees
414
Web
https://www.biolifesolutions.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PVCIX12.670.04
+0.32%
Palm Valley Capital Institutional
PGIEX34.460.06
+0.17%
Putnam Focused Equity C
PLGAX16.76N/A
N/A
Principal LargeCap Growth I A
LADSX25.45-0.02
-0.08%
Lord Abbett Developing Growth R4
WIFMX3.83-0.01
-0.26%
Wasatch Frontier Emerg Sm Countrs Instl

BLFS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+2.62%
RGEN - BLFS
59%
Loosely correlated
+2.41%
RVTY - BLFS
51%
Loosely correlated
+2.83%
A - BLFS
50%
Loosely correlated
+2.12%
DHR - BLFS
47%
Loosely correlated
+2.22%
ITGR - BLFS
46%
Loosely correlated
+1.89%
More

Groups containing BLFS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+2.62%
Pharmaceuticals
category (386 stocks)
45%
Loosely correlated
+0.12%
Pharmaceuticals: Other
category (103 stocks)
41%
Loosely correlated
+0.41%